Importance of prostate volume in the European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators: results from the prostate biopsy collaborative group

被引：0
|
作者：
Monique J. Roobol
F. H. Schröder
Jonas Hugosson
J. Stephen Jones
Michael W. Kattan
Eric A. Klein
Freddie Hamdy
David Neal
Jenny Donovan
Dipen J. Parekh
Donna Ankerst
George Bartsch
Helmut Klocker
Wolfgang Horninger
Amine Benchikh
Gilles Salama
Arnauld Villers
Stephen J. Freedland
Daniel M. Moreira
Andrew J. Vickers
Hans Lilja
Ewout W. Steyerberg
机构：
[1] Erasmus University Medical Centre,Department of Urology
[2] Sahlgrenska University Hospital,undefined
[3] Cleveland Clinic Foundation,undefined
[4] Oxford University,undefined
[5] Cambridge University,undefined
[6] Bristol University,undefined
[7] University of Texas Health Science Center at San Antonio,undefined
[8] Technische Universitaet Muenchen,undefined
[9] Innsbruck Medical University,undefined
[10] Hôpital Bichat-Claude Bernard,undefined
[11] Centre Hospitalier Intercommunal Castres-Mazamet,undefined
[12] Hôpital Huriez,undefined
[13] CHRU Lille,undefined
[14] Duke University,undefined
[15] Durham VA Medical Center,undefined
[16] Memorial Sloan-Kettering Cancer Center,undefined
来源：
World Journal of Urology | 2012年 / 30卷
关键词：
PSA; Risk; Prostate cancer; Prostate volume; Calibration; Net benefit;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：149 / 155
页数：6
相关论文
共 50 条
  • [1] Importance of prostate volume in the European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators: results from the prostate biopsy collaborative group
    Roobol, Monique J.
    Schroder, F. H.
    Hugosson, Jonas
    Jones, J. Stephen
    Kattan, Michael W.
    Klein, Eric A.
    Hamdy, Freddie
    Neal, David
    Donovan, Jenny
    Parekh, Dipen J.
    Ankerst, Donna
    Bartsch, George
    Klocker, Helmut
    Horninger, Wolfgang
    Benchikh, Amine
    Salama, Gilles
    Villers, Arnauld
    Freedland, Stephen J.
    Moreira, Daniel M.
    Vickers, Andrew J.
    Lilja, Hans
    Steyerberg, Ewout W.
    WORLD JOURNAL OF UROLOGY, 2012, 30 (02) : 149 - 155
  • [2] Comparison between the European Randomized Study for Screening of Prostate Cancer (ERSPC) and Prostate Biopsy Collaborative Group (PBCG) risk calculators: Prediction of clinically significant prostate cancer risk in a cohort of patients from Argentina
    Villota, P. M. Orbe
    Centeno, J. A. Leiva
    Lugones, J.
    Minuzzi, P. G.
    Varea, S. M.
    ACTAS UROLOGICAS ESPANOLAS, 2024, 48 (03): : 210 - 217
  • [3] NO EXCESS MORTALITY AFTER PROSTATE BIOPSY: RESULTS FROM THE EUROPEAN RANDOMIZED STUDY OF SCREENING FOR PROSTATE CANCER (ERSPC)
    Carlsson, S. C.
    Holmberg, E.
    Auvinen, A. P.
    Moss, S. M.
    Roobol, M. J.
    Schroder, F. H.
    Tammela, T. L. J.
    Aus, G.
    Hugosson, J.
    EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (02) : 302 - 303
  • [4] European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators significantly outperform the Prostate Cancer Prevention Trial (PCPT) 2.0 in the prediction of prostate cancer: a multi-institutional study
    Foley, Robert W.
    Maweni, Robert M.
    Gorman, Laura
    Murphy, Keefe
    Lundon, Dara J.
    Durkan, Garrett
    Power, Richard
    O'Brien, Frank
    O'Malley, Kieran J.
    Galvin, David J.
    Murphy, T. Brendan
    Watson, R. William
    BJU INTERNATIONAL, 2016, 118 (05) : 706 - 713
  • [5] Prostate cancer risk prediction using the novel versions of the European Randomised Study for Screening of Prostate Cancer (ERSPC) and Prostate Cancer Prevention Trial (PCPT) risk calculators: independent validation and comparison in a contemporary European cohort
    Poyet, Cedric
    Nieboer, Daan
    Bhindi, Bimal
    Kulkarni, Girish S.
    Wiederkehr, Caroline
    Wettstein, Marian S.
    Largo, Remo
    Wild, Peter
    Sulser, Tullio
    Hermanns, Thomas
    BJU INTERNATIONAL, 2016, 117 (03) : 401 - 408
  • [6] SCREENING FOR PROSTATE CANCER: RESULTS OF THE ROTTERDAM SECTION OF THE EUROPEAN RANDOMIZED STUDY OF SCREENING FOR PROSTATE CANCER (ERSPC)
    Roobol, Monique J.
    Bangma, Chris H.
    Schroder, Fritz H.
    JOURNAL OF UROLOGY, 2013, 189 (04): : E792 - E792
  • [7] Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up
    Schroder, Fritz H.
    Hugosson, Jonas
    Roobol, Monique J.
    Tammela, Teuvo L. J.
    Zappa, Marco
    Nelen, Vera
    Kwiatkowski, Maciej
    Lujan, Marcos
    Maattanen, Liisa
    Lilja, Hans
    Denis, Louis J.
    Recker, Franz
    Paez, Alvaro
    Bangma, Chris H.
    Carlsson, Sigrid
    Puliti, Donella
    Villers, Arnauld
    Rebillard, Xavier
    Hakama, Matti
    Stenman, Ulf-Hakan
    Kujala, Paula
    Taari, Kimmo
    Aus, Gunnar
    Huber, Andreas
    van der Kwast, Theo H.
    van Schaik, Ron H. N.
    de Koning, Harry J.
    Moss, Sue M.
    Auvinen, Anssi
    LANCET, 2014, 384 (9959): : 2027 - 2035
  • [8] The Prostate Cancer Prevention Trial and European Randomized Study of Screening for Prostate Cancer risk calculators indicating a positive prostate biopsy: a comparison
    van den Bergh, Roderick C. N.
    Roobol, Monique J.
    Wolters, Tineke
    van Leeuwen, Pim J.
    Schroder, Fritz H.
    BJU INTERNATIONAL, 2008, 102 (09) : 1068 - 1073
  • [9] Prediction of Prostate Cancer Risk: The Role of Prostate Volume and Digital Rectal Examination in the ERSPC Risk Calculators
    Roobol, Monique J.
    van Vugt, Heidi A.
    Loeb, Stacy
    Zhu, Xiaoye
    Bul, Meelan
    Bangma, Chris H.
    van Leenders, Arno G. L. J. H.
    Steyerberg, Ewout W.
    Schroder, Fritz H.
    EUROPEAN UROLOGY, 2012, 61 (03) : 577 - 583
  • [10] Re: Screening and Prostate Cancer Mortality: Results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 Years of Follow-up
    Bill-Axelson, Anna
    Bratt, Ola
    EUROPEAN UROLOGY, 2015, 67 (01) : 175 - 175
12345